COMMUNIQUÉS West-GlobeNewswire

QIAGEN to enhance the identification of human remains of Indigenous people and African Americans
08/07/2024
Partnership with University of Montana drives the implementation of next-generation sequencing and forensic investigative genetic genealogy in identifying human remains // QIAGEN provides instruments, kits and training [...]
Teladoc Health Announces Employee Inducement Awards under NYSE Rule 303A.08
08/07/2024
PURCHASE, NY, July 08, 2024 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE:TDOC), the global leader in whole-person virtual care, today announced that it issued inducement awards to two new employees. Effective July 1, [...]
Cartesian Therapeutics Announces New Employment Inducement Grants
08/07/2024
GAITHERSBURG, Md., July 08, 2024 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the “Company”), a clinical-stage biotechnology company developing mRNA cell therapies for the treatment of autoimmune [...]
Option Care Health to Announce Second Quarter 2024 Financial Results and Host Conference Call
08/07/2024
BANNOCKBURN, Ill., July 08, 2024 (GLOBE NEWSWIRE) -- Option Care Health Inc. (“Option Care Health”) (NASDAQ: OPCH), the nation’s largest independent provider of home and alternate site infusion services, today announced [...]
Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
08/07/2024
BEDFORD, Mass., July 08, 2024 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ:OCUL) (“Ocular”, the “Company” ), a biopharmaceutical company committed to enhancing people’s vision and quality of life through the [...]
Revolution Medicines to Provide Update on RMC-6236 Pancreatic Ductal Adenocarcinoma Clinical Program on July 15, 2024
08/07/2024
REDWOOD CITY, Calif., July 08, 2024 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing targeted therapies for patients with RAS-addicted cancers, today announced [...]
NEXGEL Announces Preliminary Record Second Quarter 2024 Revenue of $1.4 Million and Issues Revenue Guidance for Third and Fourth Quarter of 2024 of $2.2 Million and $2.6 Million, Respectively
08/07/2024
LANGHORNE, Pa., July 08, 2024 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: NXGL), a leading provider of medical and over-the-counter (OTC) products including ultra-gentle, high-water-content [...]
Kymera Announces Expansion of KT-474 (SAR444656) HS and AD Phase 2 Studies Following Interim Review of Safety and Efficacy
08/07/2024
WATERTOWN, Mass., July 08, 2024 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of small molecule medicines using targeted protein [...]
MESA LABS DECLARES QUARTERLY DIVIDEND
08/07/2024
Lakewood, Colo, July 08, 2024 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today announced that its Board of Directors has declared a regular quarterly dividend of $0. [...]
Point-of-Care Ultrasound Certification Academy and ThinkSono Announce Strategic Partnership to Enhance Deep Vein Thrombosis (DVT) Detection Skills
08/07/2024
Partnership aims to improve patient outcomes by streamlining the proficient use of POCUS making ultrasound more accessible to healthcare professionals worldwide ROCKVILLE, Md., July 08, 2024 (GLOBE NEWSWIRE) -- Inteleos [...]
Boehringer Ingelheim produces its own green energy
08/07/2024
German Vice Chancellor and Federal Minister of Economics Robert Habeck inaugurates new biomass power plant Ingelheim site can cover 95% of its energy needs from renewable sources New power plant helps achieve the [...]
Oxurion signs a Letter of Intent and enters into exclusive negotiations to potentially acquire a pioneering French CRO in stem cell production
08/07/2024
Oxurion signs a Letter of Intent and enters into exclusive negotiations to potentially acquire a pioneering French CRO in stem cell production LEUVEN, BELGIUM - July 8, 2024 – 6:30 pm , Oxurion NV (Euronext Brussels: [...]
Half-year statement of IPSEN liquidity agreement - 2024 06 30
08/07/2024
Half-year statement of IPSEN liquidity agreement with NATIXIS ODDO BHF PARIS, FRANCE, July 8, 2024 - Under the liquidity agreement entrusted by IPSEN SA to NATIXIS ODDO BHF, as of June 30, 2024, the following resources [...]
Bilan semestriel du contrat de liquidité d'IPSEN - 2024 06 30
08/07/2024
Bilan semestriel du contrat de liquidité entre IPSEN et NATIXIS ODDO BHF PARIS, FRANCE, le 8 juillet 2024 - Au titre du contrat de liquidité confié par IPSEN SA à NATIXIS ODDO BHF, à la date du 30 juin 2024, les [...]
Roche to reintroduce Susvimo in the US for people with neovascular age-related macular degeneration (nAMD)
08/07/2024
The FDA has approved updates to Susvimo, which will be available to US retina specialists and patients with nAMD in the coming weeks Susvimo offers the first alternative to regular eye injections that are standard of [...]
Team Red, White & Blue Partners with University of Health and Performance to Empower Veterans Through Health and Wellness Education
08/07/2024
BENTONVILLE, Ark., July 08, 2024 (GLOBE NEWSWIRE) -- Team Red, White & Blue (Team RWB), America's leading health and wellness community for veterans, is proud to announce a new partnership with the University of [...]
NCDHHS Problem Gambling Program, ECU’s Gambling Research and Policy Initiative, and Birches Health join forces to provide access to metrics-based clinical treatment
08/07/2024
GREENVILLE, N.C., July 08, 2024 (GLOBE NEWSWIRE) -- The North Carolina Department of Health and Human Services’ (NCDHHS) Problem Gambling Program, ECU’s Gambling Research and Policy Initiative (“GRPI”), and Birches [...]
Nutrify Today's Global C-Suite Sumflex 2024 Concludes with a Major Emphasis on India's Mission $100 Billion
08/07/2024
MUMBAI, India, July 08, 2024 (GLOBE NEWSWIRE) -- The highly anticipated global Nutrify Today C-Suite Sumflex 2024 has successfully concluded in Mumbai at The Taj Mahal Palace hotel, spotlighting India's Mission $100 [...]
RS BioTherapeutics Announces Research Collaboration with University of Colorado School of Medicine
08/07/2024
Collaboration to focus on RS BioTherapeutics’ first-in-class, steroid-free, therapeutic platform in the treatment of deadly lung diseases and use as a chemical countermeasure CUMBERLAND, Md., July 08, 2024 (GLOBE [...]

Pages